Dangers and Unreliability of Mammography: Breast Examination is a Safe, Effective, and Practical Alternative by Samuel S. Epstein, Rosalie Bertell, and Barbara Seaman International Journal of Health Services, 31(3):605-615, 2001. Mammography screening is a profit-driven technology posing risks compounded by unreliability. In striking contrast, annual clinical breast examination (CBE) by a trained health professional, together with monthly breast self-examination (BSE), is safe, at least as effective, and low in cost. International programs for training nurses how to perform CBE and teach BSE are critical and overdue. Contrary to popular belief and assurances by the U. S. media and the cancer establishment- the National Cancer Institute (NCI) and American Cancer Society.
SUTTON, England, Mar 01, 2005 (United Press International via COMTEX) — Tamoxifen use has been associated with an increased risk of endometrial cancer, a British study said. Anthony J. Swerdlow, of the Institute of Cancer Research in Sutton, England, found the risk is similar in pre- and postmenopausal women. Swerdlow’s study involved 813 British patients who had endometrial cancer following breast cancer diagnosis and 1,067 control subjects who had breast cancer but not subsequent endometrial cancer. Overall, tamoxifen treatment was associated with 2.4 times the risk of endometrial cancer compared with no treatment. The risk increased with the duration of treatment and did not diminish in the five years following.